600+ sources. One page. See who else covered it.
A nationwide Veterans Affairs (VA) study comparing two leading treatments for metastatic prostate cancer may help doctors choose the right drug for each patient, said a Rutgers Cancer Institute physician-scientist whose invited editorial accompanies the research.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
Sionna Therapeutics’ bid to become the next cystic fibrosis drug developer after Vertex Pharmaceuticals has taken a major hit, after Sionna reported that its lead asset failed an early study and ...
Actio Biosciences, which will receive $820 million up front in the deal, adds to a major upswing in private biotech buyouts seen throughout this year.
AbCellera’s share price {$ABCL} climbed about 31% by mid-morning Monday after the biotech shared positive data from a mid-stage hot flashes trial that surpassed Wall Street's expectations.
The sector added 22,000 jobs in July, well below the monthly average of 36,000 new jobs added in the past year. Still, healthcare buoyed what was otherwise a weaker-than-expected report for the…
Several agitators and four policemen were injured during a clash near the Jharkhand assembly on Monday, as police used water cannons, tear gas and lathi-charged job aspirants protesting against the…
NDLEA and Nigerian Army recover 604kg of skunk cannabis and arrest nine suspects in Edo State. A manhunt is underway for a fleeing drug kingpin.